Increased thrombin generation and circulating levels of tumour necrosis factor-α in patients with chronic Helicobacter pylori-positive gastritis

Alimentary Pharmacology and Therapeutics

Volumn 20, Issue 3, 2004, Pages 289-294

  Consolazio, A ^a,d   Borgia, M C ^a   Ferro, D ^b   Iacopini, F ^a   Paoluzi, O A ^a   Crispino, P ^a   Nardi, F ^b,c   Rivera, M ^a   Paoluzi, P ^a  

^a Gastroenterology Unit   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Department of Pathology ^*  (Italy)

^d POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE FRAGMENT; PROTHROMBIN; THROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CHRONIC GASTRITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBIN TIME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BLOOD COAGULATION; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; THROMBIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4043096223     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02074.x     Document Type: Article

References (34)

1. Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. BMJ 1994; 71: 437-9.
2. Danesh J, Peto R. Risk factor for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998; 316: 1130-2.
3. Danesh J, Youngman L, Clark S, et al. Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ 1999; 319: 1157-62.
4. Murray LJ, Bamford KB, O'Reilly DPJ, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J 1995; 74: 497-501.
5. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-50.
6. Nawroth PP, Stern D. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 740-5.
7. Schwager I, Jungi TW. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood 1994; 83: 152-60.
8. Conkling PR, Greenberg CS, Weinberg JB. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 1988; 72: 128-33.
9. Bauer KA, ten Cate H, Barzegar S, et al. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 1989; 74: 165-72.
10. Violi F, Ferro D, Basili S, et al. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 1995; 109: 531-9.
11. Van der Poll T, Buller HR, ten Cate H, et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322: 1622-7.
12. Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood 1987; 70: 343-50.
13. Crabtree JE, Shallcross TM, Heatley RV, et al. Mucosal tumor necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32: 1473-7.
14. Brodger K, Wyatt JI, Heatley RV. Gastric mucosal secretion of interleukin-10: relation to histopathology. Helicobacter pylori status, and tumor necrosis factor alpha secretion. Gut 1997; 40: 739-44.
15. Russo F, Jirillo E, Clemente C, et al. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori. Immunopharmacol Immunotoxicol 2001; 23: 13-24.
16. Scuderi P, Sterling K, Lam K, et al. Raised serum levels of tumor necrosis factors in parasitic infections. Lancet 1986; 2: 1364-5.
17. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd edn. Oxford, UK: Blackwell Scientific Publications, 1990: 200-15.
18. Khurshid A, Fenske T, Bajwa T, et al. A prospective, controlled study of Helicobacter pylori seroprevalence in coronary artery disease. Am J Gastroenterol 1998; 93: 717-20.
19. Tsai CJ, Huang TY. Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease. Dig Dis Sci 2000; 45: 1227-32.
20. Giannitsis E, Siemens HJ, Mitusch R, et al. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis. Int J Cardiol 1999; 68: 269-74.
21. Biasucci LM, Liuzzo G, Caligiuri G, et al. Temporal relation between ischemic episodes and activation of the coagulation system in unstable angina. Circulation 1996; 93: 2121-7.
22. Merlini PA, Bauer KA, Oltrona L, et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994; 90: 61-8.
23. Manten A, De Winter RJ, Minnema MC, et al. Procoagulant and proinflammatory activity in acute coronary syndromes. Cardiovasc Res 1998; 40: 389-95.
24. Martinez-Sales V, Vila V, Reganon E, et al. Elevated thrombotic activity after myocardial infarction: a 2-year follow-up study. Haemostasis 1998; 28: 301-6.
25. Bauer KA, Weiss LM, Sparrow D, et al. Aging-associated changes in indices of thrombin generation and protein C activation in humans. J Clin Invest 1987; 80: 1527-34.
26. Schumacher A, Seljeflot I, Lerkerod AB, et al. Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease. Atherosclerosis 2002; 164: 153-60.
27. Pasceri V, Cammarota G, Patti G, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998; 97: 1675-9.
28. Gunn M, Stephens JC, Thompson JR, et al. Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000; 84: 267-71.
29. Singh RK, McMahon AD, Patel H, et al. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart 2002; 88: 43-6.
30. Sung JJ, Sanderson JE. Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. Heart 1996; 76: 305-7.
31. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-81.
32. Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 1986; 77: 1909-16.
33. Fryer RH, Wilson BD, Gubler DB, et al. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 1993; 13: 1327-33.
34. Lentz SR, Sobey CG, Piegors DJ, et al. Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia. J Clin Invest 1996; 98: 24-9.